Related Experiment Videos
Prevention of neonatal hyperbilirubinemia in rhesus monkeys by tin-protoporphyrin
Insights
Tin-protoporphyrin IX effectively lowered bilirubin levels in newborn rhesus monkeys, preventing physiologic hyperbilirubinemia. This metalloporphyrin shows promise in managing neonatal jaundice, though some toxicity was observed.
Area of Science:
- Biochemistry
- Neonatal Medicine
- Pharmacology
Background:
- Physiologic hyperbilirubinemia is a common condition in newborns.
- Microsomal heme oxygenase plays a key role in bilirubin production.
- Metalloporphyrins are potential inhibitors of heme oxygenase.
Purpose of the Study:
- To evaluate the effectiveness of tin-protoporphyrin IX in preventing neonatal hyperbilirubinemia in rhesus monkeys.
- To assess the impact of tin-protoporphyrin IX on bilirubin production in neonates.
Main Methods:
- Rhesus monkey infants were injected subcutaneously at birth with tin-protoporphyrin IX (12-100 mumol).
- Serum bilirubin levels were monitored over 24-30 hours.
- Control neonates received saline injections.
Main Results:
- Neonates treated with tin-protoporphyrin IX showed a rapid decline in elevated unconjugated serum bilirubin levels.
- Bilirubin levels in treated infants reached near adult levels within 24-30 hours.
- Control neonates exhibited normal physiologic hyperbilirubinemia (3-6 mg/dl).
- Two of six animals treated with tin-protoporphyrin IX displayed signs of toxicity.
Conclusions:
- Tin-protoporphyrin IX is effective in reducing bilirubin production and preventing physiologic hyperbilirubinemia in simian neonates.
- The study establishes the therapeutic potential of tin-protoporphyrin IX for neonatal jaundice.
- Further investigation is warranted to address observed toxicity in some subjects.
Abstract:
Rhesus monkey infants were injected subcutaneously at birth with 12 to 100 mumol of tin-protoporphyrin IX, a competitive inhibitor of microsomal heme oxygenase. The elevated unconjugated serum bilirubin levels of the neonates receiving this metalloporphyrin rapidly declined to near adult levels by 24-30 h. Control neonates which received an injection of saline exhibited normal physiologic hyperbilirubinemias of from 3-6 mg/dl by 12-24 h as expected. These studies establish the effectiveness of tin-protoporphyrin IX in depressing bilirubin production and preventing physiologic hyperbilirubinemia in simian neonates. Two of six animals receiving the metalloporphyrin exhibited signs of toxicity.